Other dermatomyositis (non-juvenile, adult-onset) with documented involvement of an organ system other than the respiratory tract or musculature — such as cardiac, gastrointestinal, or cutaneous visceral complications.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- General
Documentation tips
What should appear in the chart to support M33.19.
Source · Editorial brief grounded in 5 cited references ↓
- Specify the exact organ system involved beyond muscle and respiratory — cardiac, gastrointestinal, renal, or hepatic — with supporting objective findings (e.g., elevated troponin, modified barium swallow result, echocardiogram).
- Explicitly document adult onset or non-juvenile presentation to distinguish M33.1x from M33.0x (juvenile dermatomyositis).
- Record whether myopathy is present or absent as a concurrent finding; if myopathy coexists with another organ involvement, consider whether M33.12 or M33.19 better captures the primary diagnosis.
- Include laboratory findings supporting inflammatory myopathy: CK, aldolase, LDH, anti-Jo-1 or other myositis-specific antibodies, and EMG or muscle biopsy results.
- Document that respiratory involvement is absent or separately addressed if coding M33.19 — respiratory involvement belongs under M33.11, not M33.19.
Related CPT procedures
Procedure codes commonly billed with M33.19. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M33.19 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M33.19 for juvenile dermatomyositis with other organ involvement — that presentation requires M33.09, not M33.19.
- Defaulting to M33.10 (organ involvement unspecified) when the organ system is actually documented in the note — specificity is required when the record supports it.
- Confusing M33.11 (respiratory involvement) with M33.19 — interstitial lung disease or pulmonary fibrosis complicating dermatomyositis belongs under M33.11.
- Omitting secondary codes for specific organ manifestations; M33.19 identifies the systemic category but does not capture the distinct complication — append codes like J84.10 or K22.4 as appropriate.
- Applying M33.19 to polymyositis — polymyositis with other organ involvement maps to M33.29, a separate and distinct code.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M33.19 applies to adult-onset dermatomyositis (parent code M33.1) when organ involvement is present and that involvement is neither respiratory (M33.11) nor limited to myopathy (M33.12). Classic examples include cardiac involvement (elevated troponin, arrhythmia), dysphagia from esophageal dysmotility confirmed by modified barium swallow, or gastrointestinal manifestations. If the organ system involved is the lungs — interstitial lung disease, pulmonary fibrosis — use M33.11 instead.
Do not use M33.19 for juvenile dermatomyositis with other organ involvement; that maps to M33.09. Do not use it when organ involvement is unspecified; that maps to M33.10. The distinction between M33.12 (with myopathy) and M33.19 (with other organ involvement) matters — if both myopathy and another organ system are documented, code each manifestation fully and apply the code that captures the primary presenting condition, or use additional codes for all documented involvement.
M33.19 is billable and specific as of FY2026 (effective October 1, 2025). It falls under Chapter 13: Diseases of the Musculoskeletal System and Connective Tissue (M00–M99). Additional codes for specific manifestations — such as J84.10 for pulmonary fibrosis or K22.4 for esophageal dyskinesia — may be assigned alongside M33.19 to fully capture clinical complexity.
Sibling codes
Other billable codes under M33.1 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What distinguishes M33.19 from M33.12?
02Can M33.19 be used if the patient also has respiratory involvement?
03Is M33.19 appropriate for a child diagnosed with dermatomyositis and cardiac involvement?
04What secondary codes are typically paired with M33.19?
05How does M33.19 differ from M33.29?
06Does M33.19 require a 7th-character extension?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M30-M36/M33-/M33.19
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M33.19
- 04outsourcestrategies.comhttps://www.outsourcestrategies.com/blog/code-dermatomyositis-common-rheumatology-disorder/
- 05icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M30-M36/M33-
Mira AI Scribe
The Mira AI Scribe captures the treating clinician's documentation of non-juvenile dermatomyositis with organ involvement beyond respiratory or muscular systems — including the specific organ affected, objective diagnostic support (troponin levels, barium swallow, echocardiogram findings), and confirmation of adult onset. This prevents claim downcoding to the unspecified M33.10 and blocks audit flags triggered by an unsupported 'other organ involvement' assertion.
See how Mira captures M33.19 documentation